National Academies Press: OpenBook
« Previous: V Postscript
Suggested Citation:"Appendixes." Institute of Medicine. 1996. Blood Banking and Regulation: Procedures, Problems, and Alternatives. Washington, DC: The National Academies Press. doi: 10.17226/5310.
×

Appendixes

Suggested Citation:"Appendixes." Institute of Medicine. 1996. Blood Banking and Regulation: Procedures, Problems, and Alternatives. Washington, DC: The National Academies Press. doi: 10.17226/5310.
×
This page in the original is blank.
Suggested Citation:"Appendixes." Institute of Medicine. 1996. Blood Banking and Regulation: Procedures, Problems, and Alternatives. Washington, DC: The National Academies Press. doi: 10.17226/5310.
×

A
Negotiated Rule-Making Procedure

[Added November 29, 1990]

5 U.S. Code §§ 561 et seq.

Preamble The Congress makes the following findings:
  1. Government regulation has increased substantially since the enactment of the Administrative Procedure Act.

  2. Agencies currently use rulemaking procedures that may discourage the affected parties from meeting and communicating with each other, and may cause parties with different interests to assume conflicting and antagonistic positions and to engage in expensive and time-consuming litigation over agency rules.

  3. Adversarial rulemaking deprives the affected parties and the public of the benefits of face-to-face negotiations and cooperation in developing and reaching agreement on a rule. It also deprives them of the benefits of shared information, knowledge, expertise, and technical abilities possessed by the affected parties.

  4. Negotiated rulemaking, in which the parties who will be significantly affected by a rule participate in the development of the rule, can provide significant advantages over adversarial rulemaking.

  5. Negotiated rulemaking can increase the acceptability and improve the substance of rules, making it less likely that the affected parties will resist enforcement or challenge such rules in court. It may also shorten the amount of time needed to issue final rules.

  6. Agencies have the authority to establish negotiated rulemaking committees under the laws establishing such agencies and their activities and under the Federal Advisory Committee Act (5 U.S.C. App.). Several agencies have successfully used negotiated rulemaking. The process has not been widely used by other agencies, however, in part because such

Suggested Citation:"Appendixes." Institute of Medicine. 1996. Blood Banking and Regulation: Procedures, Problems, and Alternatives. Washington, DC: The National Academies Press. doi: 10.17226/5310.
×

agencies are unfamiliar with the process or uncertain as to the authority for such rulemaking.

§ 561. Purpose

The purpose of this subchapter is to establish a framework for the conduct of negotiated rulemaking, consistent with section 553 of this title, to encourage agencies to use the process when it enhances the informal rulemaking process. Nothing in this subchapter should be construed as an attempt to limit innovation and experimentation with the negotiated rulemaking process or with other innovative rulemaking procedures otherwise authorized by law.

§ 562. Definitions

For the purposes of this subchapter the term—

  1. "agency" has the same meaning as in section 551(1) of this title;

  2. "consensus" means unanimous concurrence among the interests represented on a negotiated rulemaking committee established under this subchapter unless such committee—

    1. agrees to define such term to mean a general but not unanimous concurrence; or

    2. agrees upon another specified definition;

  1. "convener" means a person who impartially assists an agency in determining whether establishment of a negotiated rulemaking committee is feasible and appropriate in a particular rulemaking;

  2. "facilitator" means a person who impartially aids in the discussions and negotiations among the members of a negotiated rulemaking committee to develop a proposed rule;

  3. "interest" means, with respect to an issue or matter, multiple parties which have a similar point of view or which are likely to be affected in a similar manner;

  4. "negotiated rulemaking" means rulemaking through the use of a negotiated rulemaking committee;

Suggested Citation:"Appendixes." Institute of Medicine. 1996. Blood Banking and Regulation: Procedures, Problems, and Alternatives. Washington, DC: The National Academies Press. doi: 10.17226/5310.
×
  1. "negotiated rulemaking committee" or "committee" means an advisory committee established by an agency in accordance with this Subchapter and the Federal Advisory Committee Act to consider and discuss issues for the purpose of reaching a consensus in the development of a proposed rule;

  2. "party" has the same meaning as in section 551(3) of this title;

  3. "person" has the same meaning as in section 551(2) of this title;

  4. "rule" has the same meaning as in section 551(4) of this title; and

  5. "rulemaking" means "rule making" as that term is defined in section 551(5) of this title.

§ 563. Determination of need for negotiated rulemaking committee
  1. Determination of need by the agency. An agency may establish a negotiated rulemaking committee to negotiate and develop a proposed rule, if the head of the agency determines that the use of the negotiated rulemaking procedure is in the public interest. In making such a determination, the head of the agency shall consider whether—

    1. there is a need for a rule;

    2. there are a limited number of identifiable interests that will be significantly affected by the rule;

    3. there is a reasonable likelihood that a committee can be convened with a balanced representation of persons who—

      1. can adequately represent the interests identified under paragraph (2); and

      2. are willing to negotiate in good faith to reach a consensus on the proposed rule;

    1. there is a reasonable likelihood that a committee will reach a consensus on the proposed rule within a fixed period of time;

    2. the negotiated rulemaking procedure will not unreasonably delay the notice of proposed rulemaking and the issuance of the final rule;

Suggested Citation:"Appendixes." Institute of Medicine. 1996. Blood Banking and Regulation: Procedures, Problems, and Alternatives. Washington, DC: The National Academies Press. doi: 10.17226/5310.
×
  1. the agency has adequate resources and is willing to commit such resources, including technical assistance, to the committee; and

  2. the agency, to the maximum extent possible consistent with the legal obligations of the agency, will use the consensus of the committee with respect to the proposed rule as the basis for the rule proposed by the agency for notice and comment.

  1. Use of conveners.

    1. Purposes of conveners. An agency may use the services of a convener to assist the agency in—

      1. identifying persons who will be significantly affected by a proposed rule, including residents of rural areas; and

      2. conducting discussions with such persons to identify the issues of concern to such persons, and to ascertain whether the establishment of a negotiated rulemaking committee is feasible and appropriate in the particular rulemaking.

    1. Duties of conveners. The convener shall report findings and may make recommendations to the agency. Upon request of the agency, the convener shall ascertain the names of persons who are willing and qualified to represent interests that will be significantly affected by the proposed rule, including residents of rural areas. The report and any recommendations of the convener shall be made available to the public upon request

§ 564. Publication of notice; applications for membership on committees
  1. Publication of notice. If, after considering the report of a convener or conducting its own assessment, an agency decides to establish a negotiated rulemaking committee, the agency shall publish in the Federal Register and, as appropriate, in trade or other specialized publications, a notice which shall include—

    1. an announcement that the agency intends to establish a negotiated rulemaking committee to negotiate and develop a proposed rule;

    2. a description of the subject and scope of the rule to be developed, and the issues to be considered;

Suggested Citation:"Appendixes." Institute of Medicine. 1996. Blood Banking and Regulation: Procedures, Problems, and Alternatives. Washington, DC: The National Academies Press. doi: 10.17226/5310.
×
  1. a list of the interests which are likely to be significantly affected by the rule;

  2. a list of the persons proposed to represent such interests and the person or persons proposed to represent the agency;

  3. a proposed agenda and schedule for completing the work of the committee, including a target date for publication by the agency of a proposed rule for notice and comment;

  4. a description of administrative support for the committee to be provided by the agency, including technical assistance;

  5. a solicitation for comments on the proposal to establish the committee, and the proposed membership of the negotiated rulemaking committee; and

  6. an explanation of how a person may apply or nominate another person for membership on the committee, as provided under subsection (b).

  1. Applications for membership or committee. Persons who will be significantly affected by a proposed rule and who believe that their interests will not be adequately represented by any person specified in a notice under subsection (a)(4) may apply for, or nominate another person for, membership on the negotiated rulemaking committee to represent such interests with respect to the proposed rule. Each application or nomination shall include—

    1. the name of the applicant or nominee and a description of the interests such person shall represent;

    2. evidence that the applicant or nominee is authorized to represent parties related to the interests the person proposes to represent;

    3. a written commitment that the applicant or nominee shall actively participate in good faith in the development of the rule under consideration; and

    4. the reasons that the persons specified in the notice under subsection (a)(4) do not adequately represent the interests of the person submitting the application or nomination.

Suggested Citation:"Appendixes." Institute of Medicine. 1996. Blood Banking and Regulation: Procedures, Problems, and Alternatives. Washington, DC: The National Academies Press. doi: 10.17226/5310.
×
  1. Period for submission of comments and applications. The agency shall provide for a period of at least 30 calendar days for the submission of comments and applications under this section.

§ 565. Establishment of committee
  1. Establishment.

    1. Determination to establish committee. If after considering comments and applications submitted under section 564, the agency determines that a negotiated rulemaking committee can adequately represent the interests that will be significantly affected by a proposed rule and that it is feasible and appropriate in the particular rulemaking, the agency may establish a negotiated rulemaking committee. In establishing and administering such a committee, the agency shall comply with the Federal Advisory Committee Act with respect to such committee, except as otherwise provided in this subchapter.

    2. Determination not to establish committee. If after considering such comments and applications, the agency decides not to establish a negotiated rulemaking committee, the agency shall promptly publish notice of such decision and the reasons therefor in the Federal Register and, as appropriate, in trade or other specialized publications, a copy of which shall be sent to any person who applied for, or nominated another person for membership on the negotiating rulemaking committee to represent such interests with respect to the proposed rule.

  1. Membership. The agency shall limit membership on a negotiated rulemaking committee to 25 members, unless the agency head determines that a greater number of members is necessary for the functioning of the committee or to achieve balanced membership. Each committee shall include at least one person representing the agency.

  2. Administrative support. The agency shall provide appropriate administrative support to the negotiated rulemaking committee, including technical assistance.

Suggested Citation:"Appendixes." Institute of Medicine. 1996. Blood Banking and Regulation: Procedures, Problems, and Alternatives. Washington, DC: The National Academies Press. doi: 10.17226/5310.
×
§ 566. Conduct of committee activity
  1. Duties of committee. Each negotiated rulemaking committee established under this subchapter shall consider the matter proposed by the agency for consideration and shall attempt to reach a consensus concerning a proposed rule with respect to such matter and any other matter the committee determines is relevant to the proposed rule.

  2. Representatives of agency on committee. The person or persons representing the agency on a negotiated rulemaking committee shall participate in the deliberations and activities of the committee with the same rights and responsibilities as other members of the committee, and shall be authorized to fully represent the agency in the discussions and negotiations of the committee.

  3. Selecting facilitator. Notwithstanding section 10(e) of the Federal Advisory Committee Act an agency may nominate either a person from the Federal Government or a person from outside the Federal Government to serve as a facilitator for the negotiations of the committee, subject to the approval of the committee by consensus. If the committee does not approve the nominee of the agency for facilitator, the agency shall submit a substitute nomination. If a committee does not approve any nominee of the agency for facilitator, the committee shall select by consensus a person to serve as facilitator. A person designated to represent the agency in substantive issues may not serve as facilitator or otherwise chair the committee.

  4. Duties of facilitator. A facilitator approved or selected by a negotiated rulemaking committee shall—

    1. chair the meetings of the committee in an impartial manner;

    2. impartially assist the members of the committee in conducting discussions and negotiations; and

    3. manage the keeping of minutes and records as required under section 10(b) and (c) of the Federal Advisory Committee Act, except that any personal notes and materials of the facilitator or of the members of a committee shall not be subject to section 552 of this title.

  1. Committee procedures. A negotiated rulemaking committee established under this subchapter may adopt procedures for the operation of

Suggested Citation:"Appendixes." Institute of Medicine. 1996. Blood Banking and Regulation: Procedures, Problems, and Alternatives. Washington, DC: The National Academies Press. doi: 10.17226/5310.
×

the committee. No provision of section 553 of this title shall apply to the procedures of a negotiated rulemaking committee.

  1. Report of committee. If a committee reaches a consensus on a proposed rule, at the conclusion of negotiations the committee shall transmit to the agency that established the committee a report containing the proposed rule. If the committee does not reach a consensus on a proposed rule, the committee may transmit to the agency a report specifying any areas in which the committee reached a consensus. The committee may include in a report any other information, recommendations, or materials that the committee considers appropriate. Any committee member may include as an addendum to the report additional information, recommendations, or materials.

  2. Records of committee. In addition to the report required by subsection (f), a committee shall submit to the agency the records required under section 10(b) and (c) of the Federal Advisory Committee Act.

§ 567. Termination of committee

A negotiated rulemaking committee shall terminate upon promulgation of the final rule under consideration, unless the committee's charter contains an earlier termination date or the agency, after consulting the committee, or the committee itself specifies an earlier termination date.

§ 568. Services, facilities, and payment of committee member expenses
  1. Services of conveners and facilitators.

    1. In general. An agency may employ or enter into contracts for the services of an individual or organization to serve as a convener or facilitator for a negotiated rulemaking committee under this subchapter, or may use the services of a Government employee to act as a convener or a facilitator for such a committee.

    2. Determination of conflicting interests. An agency shall determine whether a person under consideration to serve as convener or facilitator of a committee under paragraph (1) has any financial or other interest that would preclude such person from serving in an impartial and independent manner.

Suggested Citation:"Appendixes." Institute of Medicine. 1996. Blood Banking and Regulation: Procedures, Problems, and Alternatives. Washington, DC: The National Academies Press. doi: 10.17226/5310.
×
  1. Services and facilities of other entities. For purposes of this subchapter, an agency may use the services and facilities of other Federal agencies and public and private agencies and instrumentalities with the consent of such agencies and instrumentalities, and with or without reimbursement to such agencies and instrumentalities, and may accept voluntary and uncompensated services without regard to the provisions of section 1342 of title 31. The Federal Mediation and Conciliation Service may provide services and facilities, with or without reimbursement, to assist agencies under this subchapter, including furnishing conveners, facilitators, and training in negotiated rulemaking.

  2. Expenses of committee members. Members of a negotiated rulemaking committee shall be responsible for their own expenses of participation in such committee, except that an agency may, in accordance with section 7(d) of the Federal Advisory Committee Act pay for a member's reasonable travel and per diem expenses, expenses to obtain technical assistance, and a reasonable rate of compensation, if—

    1. such member certifies a lack of adequate financial resources to participate in the committee; and

    2. the agency determines that such member's participation in the committee is necessary to assure an adequate representation of the member's interest.

  1. Status of member as Federal employee. A member's receipt of funds under this section or section 569 shall not conclusively determine for purposes of sections 202 through 209 of title 18 whether that member is an employee of the United States Government.

§ 569. Role of the Administrative Conference of the United States and other entities
  1. Consultation by agencies. An agency may consult with the Administrative Conference of the United States or other public or private individuals or organizations for information and assistance in forming a negotiated rulemaking committee and conducting negotiations on a proposed rule.

  2. Roster of potential conveners and facilitators. The Administrative Conference of the United States, in consultation with the Federal Mediation and Conciliation Service, shall maintain a roster of individuals

Suggested Citation:"Appendixes." Institute of Medicine. 1996. Blood Banking and Regulation: Procedures, Problems, and Alternatives. Washington, DC: The National Academies Press. doi: 10.17226/5310.
×

who have acted as or are interested in serving as conveners or facilitators in negotiated rulemaking proceedings. The roster shall include individuals from government agencies and private groups, and shall be made available upon request. Agencies may also use rosters maintained by other public or private individuals or organizations.

  1. Procedures to obtain conveners and facilitators.

  1. Procedures. The Administrative Conference of the United States shall develop procedures which permit agencies to obtain the services of conveners and facilitators on an expedited basis.

  2. Payment for services. Payment for the services of conveners or facilitators shall be made by the agency using the services, unless the Chairman of the Administrative Conference agrees to pay for such services under subsection (f).

  1. Compilation of data on negotiated rulemaking; report to Congress.

  1. Compilation of data. The Administrative Conference of the United States shall compile and maintain data related to negotiated rulemaking and shall act as a clearinghouse to assist agencies and parties participating in negotiated rulemaking proceedings.

  2. Submission of information by agencies. Each agency engaged in negotiated rulemaking shall provide to the Administrative Conference of the United States a copy of any reports submitted to the agency by negotiated rulemaking committees under section 566 and such additional information as necessary to enable the Administrative Conference of the United States to comply with this subsection.

  3. Reports to Congress. The Administrative Conference of the United States shall review and analyze the reports and information received under this subsection and shall transmit a biennial report to the Committee on Governmental Affairs of the Senate and the appropriate committees of the House of Representatives that—

    1. provides recommendations for effective use by agencies of negotiated rulemaking; and

    2. describes the nature and amounts of expenditures made by the Administrative Conference of the United States to accomplish the purposes of this subchapter.

Suggested Citation:"Appendixes." Institute of Medicine. 1996. Blood Banking and Regulation: Procedures, Problems, and Alternatives. Washington, DC: The National Academies Press. doi: 10.17226/5310.
×
  1. Training in negotiated rulemaking. The Administrative Conference of the United States is authorized to provide training in negotiated rulemaking techniques and procedures for personnel of the Federal Government either on a reimbursable or nonreimbursable basis. Such training may be extended to private individuals on a reimbursable basis.

  2. Payment of expenses of agencies. The Chairman of the Administrative Conference of the United States is authorized to pay, upon request of an agency, all or part of the expenses of establishing a negotiated rulemaking committee and conducting a negotiated rulemaking. Such expenses may include, but are not limited to—

    1. the costs of conveners and facilitators;

    2. the expenses of committee members determined by the agency to be eligible for assistance under section 568(c); and

    3. training costs.

Determinations with respect to payments under this section shall be at the discretion of such Chairman in furthering the use by Federal agencies of negotiated rulemaking.

  1. Use of funds of the Conference. The Administrative Conference of the United States may apply funds received under section 595(c)(12) of this title to carry out the purposes of this subchapter.

§ 570. Judicial review

Any agency action relating to establishing, assisting, or terminating a negotiated rulemaking committee under this subchapter shall not be subject to judicial review. Nothing in this section shall bar judicial review of a rule if such judicial review is otherwise provided by law. A rule which is the product of negotiated rulemaking and is subject to judicial review shall not be accorded any greater deference by a court than a rule which is the product of other rulemaking procedures.

Suggested Citation:"Appendixes." Institute of Medicine. 1996. Blood Banking and Regulation: Procedures, Problems, and Alternatives. Washington, DC: The National Academies Press. doi: 10.17226/5310.
×
This page in the original is blank.
Suggested Citation:"Appendixes." Institute of Medicine. 1996. Blood Banking and Regulation: Procedures, Problems, and Alternatives. Washington, DC: The National Academies Press. doi: 10.17226/5310.
×

B
Workshop Participants

WORKSHOP ON RISK AND REGULATION

January 23–24, 1995

Lew Barker

Efficacy Trials Branch

Vaccine and Prevention Research Program

Division of AIDS NIAID, NIH

Celso Bianco

Vice President Medical Affairs

New York Blood Center

Penny Chan, Ph.D.

Commission of Inquiry

Blood Systems in Canada

Toronto, Ontario

Harry W. Chen

HemaSure Corporation

Marlborough, MA

Eileen Church

Communications Manager

American Association of Blood Banks

Marcia Crosse

Program Evaluation and Methodology Division

U.S. General Accounting Office

Jacqueline D'Alessio, Ph.D.

U.S. General Accounting Office

Leonard I. Friedman

American Red Cross

Holland Lab

Elizabeth Goss

Fox, Bennett & Turner

Washington, DC

Harold Kaplan, M.D.

University of Texas

Southwestern Medical Center

Kurt R. Kroemer

U.S. General Accounting Office

Jan Lane

American Red Cross

Karen Shoos Lipton

CEO

American Association of Blood Banks

Jane Mackey, MBA

Topeka Blood Bank, Inc.

James MacPherson

Executive Director

Council of Community Blood Centers

Suggested Citation:"Appendixes." Institute of Medicine. 1996. Blood Banking and Regulation: Procedures, Problems, and Alternatives. Washington, DC: The National Academies Press. doi: 10.17226/5310.
×

John McCray

HemaSure Inc.

Marlborough, MA

Brian McDonough

American Red Cross

Arlington, VA

Charles Mosher

Blood Centers of America, Inc.

E. Greenwich, RI

Jean Otter

Director of Regulatory Affairs

American Association of Blood Banks

Mary K. Pendergast

Deputy Commissioner and Senior Advisor to the Commissioner

Food and Drug Administration

Barbara Peoples

American Red Cross

Holland Lab

Mark Philip

IMMUNO US, INC.

Rochester, MI

Beatrice Pierce

National Hemophilia Foundation

Rancho Santa Fe, CA

William H. Portman

The Institute for Transfusion Medicine

Pittsburgh, PA

James Reilly

Executive Director Director

American Blood Resources Association

Miriam Sparrow, Esq.

New York Blood Center, Inc.

Edwin Steane, Ph.D.

ICCBBA

Eugene Timm

IMMUNO US, INC.

Rochester, MI

Peter Tomasulo, M.D.

TM Consulting, Inc.

McLean, VA

Lee Ann Weitekamp

The Blood Center of Southeastern Wisconsin

Milwaukee, WI

WORKSHOP ON MANAGING THREATS TO THE BLOOD SUPPLY

September 21–22, 1995

Lew Barker

Efficacy Trials Branch

Vaccine and Prevention Research Program

Division of AIDS NIAID/NIH

Patricia Bezjak

Chief Operating Officer

Metropolitan Washington Blood Banks

Celso Bianco, M.D.

Vice President/Medical Affairs

New York Blood Center

Suggested Citation:"Appendixes." Institute of Medicine. 1996. Blood Banking and Regulation: Procedures, Problems, and Alternatives. Washington, DC: The National Academies Press. doi: 10.17226/5310.
×

Irene Church

American Association of Blood Banks

Brian P. Conway, Esq.

Bayer Corporation

Richard J. Davey, M.D.

Chief Medical Officer

American Red Cross

Rob Dickstein

Director, Regulatory Affairs

Pall Corporation

Sandra Ellisor

Ortho Diagnostic Systems, Inc.

Susan Frantz-Bohn

FDA/CBER

Division of Congressional and Pub Affairs

Steve Friedman

Dechert, Price, & Rhoads

Eric Goosby

Office of HIV/AIDS Policy

Elizabeth Goss

Attorney

Fox, Bennett & Turner

William J. Hammes

Associate Counsel

Bayer Corporation

Harriet Newman (MT) ASCP

Donor Advocate

Virginia Blood Services

Nancy Newman

Knapp, Petersen & Clark

Jean Otter

American Association of Blood Banks

Stephen Redhead

Analyst Congressional Research Service

Library of Congress

James Reilly

Executive Director

American Blood resources Association

Paul Schmidt, M.D.

Head, Transfusion Medicine

Transfusion Medicine Academic Center

Florida Blood Services

Toby Simon, M.D.

President and CEO

Blood Systems, Inc.

Harold C. Sox, Jr., M.D.

Chairman, Dept. of Medicine

Dartmouth-Hitchcock Medical Center

Miriam Sparrow, Esq.

New York Blood Center, Inc.

Jane Starkey

Deputy Director

Council of Community Blood Centers

Ron Welborn

Community Bioresources, Inc.

Edward Wolf

Sr. Associate General Council

American Red Cross

Sam Wortham

Group Vice President

Pall Corporation

Suggested Citation:"Appendixes." Institute of Medicine. 1996. Blood Banking and Regulation: Procedures, Problems, and Alternatives. Washington, DC: The National Academies Press. doi: 10.17226/5310.
×
This page in the original is blank.
Suggested Citation:"Appendixes." Institute of Medicine. 1996. Blood Banking and Regulation: Procedures, Problems, and Alternatives. Washington, DC: The National Academies Press. doi: 10.17226/5310.
×

C
Acronyms


ACUS

Administrative Conference of the United States

AIDS

Acquired Immune Deficiency Syndrome

ARC

American Red Cross

AABB

American Association of Blood Banks

ABRA

American Blood Resources Association


CAP

College of American Pathologists

CBER

Center for Biologics Evaluation and Research, Food and Drug Administration

CCBC

Council of Community Blood Centers

CDC

Centers for Disease Control and Prevention

CFR

Code of Federal Regulations

CLIA

Clinical Laboratories Improvement Act

CJD

Creutzfeldt-Jakob Disease


EPA

Environmental Protection Agency


FAA

Federal Aviation Administration

FACA

Federal Advisory Committee Act

FDA

Food and Drug Administration

FD&C

Food, Drug, and Cosmetic Act


GMP

good manufacturing practices


HIV

human immunodeficiency virus


NIH

National Institutes of Health


OSHA

Occupational Safety and Health Administration


PDUFA

Pharmaceutical Drug Users Fee Act

PLA

Product Licensing Application

Suggested Citation:"Appendixes." Institute of Medicine. 1996. Blood Banking and Regulation: Procedures, Problems, and Alternatives. Washington, DC: The National Academies Press. doi: 10.17226/5310.
×
Page 107
Suggested Citation:"Appendixes." Institute of Medicine. 1996. Blood Banking and Regulation: Procedures, Problems, and Alternatives. Washington, DC: The National Academies Press. doi: 10.17226/5310.
×
Page 108
Suggested Citation:"Appendixes." Institute of Medicine. 1996. Blood Banking and Regulation: Procedures, Problems, and Alternatives. Washington, DC: The National Academies Press. doi: 10.17226/5310.
×
Page 109
Suggested Citation:"Appendixes." Institute of Medicine. 1996. Blood Banking and Regulation: Procedures, Problems, and Alternatives. Washington, DC: The National Academies Press. doi: 10.17226/5310.
×
Page 110
Suggested Citation:"Appendixes." Institute of Medicine. 1996. Blood Banking and Regulation: Procedures, Problems, and Alternatives. Washington, DC: The National Academies Press. doi: 10.17226/5310.
×
Page 111
Suggested Citation:"Appendixes." Institute of Medicine. 1996. Blood Banking and Regulation: Procedures, Problems, and Alternatives. Washington, DC: The National Academies Press. doi: 10.17226/5310.
×
Page 112
Suggested Citation:"Appendixes." Institute of Medicine. 1996. Blood Banking and Regulation: Procedures, Problems, and Alternatives. Washington, DC: The National Academies Press. doi: 10.17226/5310.
×
Page 113
Suggested Citation:"Appendixes." Institute of Medicine. 1996. Blood Banking and Regulation: Procedures, Problems, and Alternatives. Washington, DC: The National Academies Press. doi: 10.17226/5310.
×
Page 114
Suggested Citation:"Appendixes." Institute of Medicine. 1996. Blood Banking and Regulation: Procedures, Problems, and Alternatives. Washington, DC: The National Academies Press. doi: 10.17226/5310.
×
Page 115
Suggested Citation:"Appendixes." Institute of Medicine. 1996. Blood Banking and Regulation: Procedures, Problems, and Alternatives. Washington, DC: The National Academies Press. doi: 10.17226/5310.
×
Page 116
Suggested Citation:"Appendixes." Institute of Medicine. 1996. Blood Banking and Regulation: Procedures, Problems, and Alternatives. Washington, DC: The National Academies Press. doi: 10.17226/5310.
×
Page 117
Suggested Citation:"Appendixes." Institute of Medicine. 1996. Blood Banking and Regulation: Procedures, Problems, and Alternatives. Washington, DC: The National Academies Press. doi: 10.17226/5310.
×
Page 118
Suggested Citation:"Appendixes." Institute of Medicine. 1996. Blood Banking and Regulation: Procedures, Problems, and Alternatives. Washington, DC: The National Academies Press. doi: 10.17226/5310.
×
Page 119
Suggested Citation:"Appendixes." Institute of Medicine. 1996. Blood Banking and Regulation: Procedures, Problems, and Alternatives. Washington, DC: The National Academies Press. doi: 10.17226/5310.
×
Page 120
Suggested Citation:"Appendixes." Institute of Medicine. 1996. Blood Banking and Regulation: Procedures, Problems, and Alternatives. Washington, DC: The National Academies Press. doi: 10.17226/5310.
×
Page 121
Suggested Citation:"Appendixes." Institute of Medicine. 1996. Blood Banking and Regulation: Procedures, Problems, and Alternatives. Washington, DC: The National Academies Press. doi: 10.17226/5310.
×
Page 122
Suggested Citation:"Appendixes." Institute of Medicine. 1996. Blood Banking and Regulation: Procedures, Problems, and Alternatives. Washington, DC: The National Academies Press. doi: 10.17226/5310.
×
Page 123
Suggested Citation:"Appendixes." Institute of Medicine. 1996. Blood Banking and Regulation: Procedures, Problems, and Alternatives. Washington, DC: The National Academies Press. doi: 10.17226/5310.
×
Page 124
Suggested Citation:"Appendixes." Institute of Medicine. 1996. Blood Banking and Regulation: Procedures, Problems, and Alternatives. Washington, DC: The National Academies Press. doi: 10.17226/5310.
×
Page 125
Blood Banking and Regulation: Procedures, Problems, and Alternatives Get This Book
×
Buy Paperback | $46.00 Buy Ebook | $36.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

This volume examines regulatory and policymaking procedures in blood banking, regulatory enforcement and compliance, innovations and alternatives in regulation, congressional oversight and regulatory initiatives, and investment in regulatory quality.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!